Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group's Data Privacy Policy. For more information, click here.

Hiring of Jonathan Bracey as Managing Director – UK

For Immediate Release

Joshua Cooper
Tanner Pharma Group

CHARLOTTE, N.C., December 1, 2015 – Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.

Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently established UK/EU operations based in London.  Prior to joining Tanner Pharma Group, Mr. Bracey led various operations in Big Pharma, Specialty Pharma, Generics and most recently consultancy within the pharmaceutical industry.  Within these organizations, he worked in general management, operations, sales, procurement, and supply chain roles with UK, EU, MENA, and Global reach.  Mr. Bracey also served in HMS as a logistics officer.

“Jonathan’s breadth of experience in leadership, operations, pharmaceuticals and business development make him an ideal Managing Director for our new UK office,” stated Banks Bourne, Founder of Chairman of Tanner Pharma Group and CEO of Bourne Partners, the parent company of Tanner Pharma Group.

The newly established UK office provides access to critical European markets where Tanner Pharma Group expects large growth in the areas of Clinical Trial Supply and Global Access Programmes.  A presence in the UK provides customer access, sourcing opportunities as well as a deep pool of human capital.  Mr. Bracey’s responsibilities will be to capitalize on this growth opportunity and scale Tanner Pharma Group in the UK and Europe.

About Tanner Pharma Group

For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.

Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.

Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.

For more information about Tanner Pharma Group, please visit www.tannerpharma.com.

Contact Us